|
The team at Wichita State University – Community Engagement Institute (WSU-CEI) would like to wish everyone a Happy New Year!
The first Learning Collaborative event of 2024 is scheduled for January 16th at 3:00 pm. If you are a leader from an OneCare Kansas (OCK) service provider organization and have not yet registered for the event, please do so. Check your email for the registration link or contact Vanessa Lohf for assistance.
In addition, the slide deck from the last in-person Learning Collaborative event is now available for reference on the OCK News and Events page.
WSU-CEI is excited to explore new learning opportunities together in 2024. Have a great New Year!
To enhance continuous improvement, the Managed Care Organizations (MCOs) have implemented improvements to the 2024 OCK Audit Tool, drawing from insights gained during the 2023 audit cycle. These revisions aim to provide clarity, consistency, and overall effectiveness for both OneCare Kansas Partners (OCKPs) and auditors, resulting in a more streamlined and focused audit experience. Key changes to the audit tool include:
These updates are expected to significantly improve OCK audits and assist providers in meeting the requirements of the OCK program. The revised 2024 OCK Audit Tool and Audit Tool Overview Document are available on the OCK website. Additionally, Appendix F of the OCK Program Manual now showcases a standardized annual audit timeline instead of being presented in a year-by-year format.
The OCK Medication Reconciliation Form has been updated to feature a text field for the "date" instead of the member's "date of birth." Providers who prefer the OCK version are advised to adopt this revised form moving forward for new members or existing members in need of a new form. The updated form is available on the Health Action Plan Documents page.
The state has enhanced the sign-up process for new OCKP staff and stakeholders interested in receiving the OCK Newsletter. A GovDelivery sign-up link is now available to them on both the OCK section of the KanCare homepage and the OCK Newsletter Library page. This update streamlines the subscription process for the OCK Newsletter and offers an easy way of managing subscriber preferences. This update has also been incorporated into Appendix D of the OCK Program Manual.
Cervical cancer remains a significant health concern for many women, progressing gradually from precancerous conditions. Cervical Cancer Awareness Month is observed in January to promote awareness about cervical cancer and the importance of early detection and prevention. By educating women about the types of cervical cancer and the importance of symptom recognition and routine screenings, they can take necessary measures to protect themselves from potential risks associated with cervical cancer.
Cervical cancer progresses slowly, often starting with dysplasia - a condition where cells multiply in cervical tissue. If left untreated, these abnormal cells may progress into cancer and spread to surrounding tissues.
Squamous cell carcinoma and adenocarcinoma are the two primary forms of cervical cancer, and they develop in different parts of the cervix. Squamous Cell Carcinoma develops on the outer part of the cervix known as the ectocervix and accounts for up to 90% of cervical cancer cases. Adenocarcinoma develops in the glandular cells of the inner cervix, known as the endocervix.
The presence of high-risk strains of human papillomavirus (HPV), a common sexually transmitted infection, is the primary risk factor for cervical cancer. Other risk factors include tobacco use, multiple sexual partners, sexually transmitted infections, and a weakened immune system.
Timely recognition of early-stage symptoms, such as postmenopausal vaginal bleeding, irregular bleeding between menstrual cycles, and abnormal vaginal discharge, is important for early detection. It is advised to seek prompt medical attention if these symptoms arise.
Cervical cancer screenings are important for detecting precancerous changes, allowing for timely intervention before they advance into cancerous cells. Healthcare professionals offer a range of screening methods, including HPV testing, Pap smears, and combined HPV/Pap co-test. Screening protocols vary by age to ensure timely intervention. Pap smears are advised every three years for women aged 21-29. Women aged 30-65 are advised to undergo HPV testing or combination tests every five years, as well as a pap smear every three years.
Understanding the gradual progression of cervical cancer, recognizing symptoms and adhering to regular screenings are essential to early detection and prevention. By being proactive and taking preventative measures, women can reduce their risk of developing cervical cancer. For more information, visit this cervical cancer article.
|
